14/04/2026 22:11
|
Medical, Health & Aged Care
INCHEON, Korea--BUSINESS WIRE--
Samsung Bioepis Co., Ltd. announced today the initiation of Phase 1 clinical trial for SBE303. SBE303 is Samsung Bioepis’s first novel antibody-drug conjugate (ADC)...